FaceYa FaceYa
搜索结果
查看所有结果
  • 加入
    登录
    注册
    搜索
    主题切换
    夜间模式

搜索

发现新朋友,建立新联系,结交新朋友

  • 最新动态
  • 探索
  • 网站页面
  • 网站群组
  • 网站活动
  • 网站博客
  • 商品优惠
  • 工作招聘
  • 学习课程
  • 网站论坛
  • 网站电影
  • 游戏娱乐
  • 帖子
  • 网站博客
  • 用户
  • 网站页面
  • 网站群组
  • 网站活动
  • Wang Judy 添加了博客 其他
    2026-05-28 08:09:27 -
    New Application Scenarios for the AS01 Adjuvant: The ACI-24.060 Alzheimer’s Disease Vaccine Project
    The treatment of Alzheimer’s Disease (AD) has entered the era of "Disease-Modifying Therapies" (DMTs). With the approval of anti-Aβ monoclonal antibodies (such as Lecanemab), the Amyloid Cascade Hypothesis has received clinical validation. However, the safety risks associated with ARIA (Amyloid-Related Imaging Abnormalities) in monoclonal antibody therapies, as well as their high...
    0 评论 0 分享 1千 浏览次数 0 评价
    请登录以点赞、分享和评论!
  • Wang Judy 添加了博客 其他
    2026-06-10 06:59:58 -
    The Potential and Advantages of Using the AS01 Adjuvant in Next-Generation Adjuvanted Influenza Vaccines
    Influenza vaccines represent one of the largest segments of the global vaccine market (with the global market size exceeding $8 billion by 2025). However, the protective efficacy of traditional split-virus vaccines has long hovered between 30% and 50% among individuals aged 65 and older and immunocompromised populations. Additionally, these vaccines require annual updates, offer short-term...
    0 评论 0 分享 1千 浏览次数 0 评价
    请登录以点赞、分享和评论!
© 2026 FaceYa 简体中文
English Arabic French Spanish Portuguese Deutsch Turkish Dutch Italiano Russian Romaian Portuguese (Brazil) Greek 简体中文 日本語 한국어 繁体中文
关于 条款 隐私设置 联系我们 目录